DIDO-2 (COSPAR 2017-008BE) is a nano-satellite of the Israeli / Swiss company SpacePharma.
[1] The nano-satellite is part of a research project whose goal is to test a miniaturized end-to-end pharmaceutical laboratory (called mGnify lab) in space under microgravity conditions.
The platforms of the 3U CubeSats are developed and built by the Dutch company ISIS.
The current (as of 2019) status and plans for this satellite are unknown.
[3] DIDO-2 was successfully launched on February 15, 2017, at 3:58 UTC from Satish Dhawan Space Centre on a PSLV-XL rocket (mission PSLV-C37) that released 104 satellites.